SCHEMBL7920260

SCHEMBL7920260

CCOC(=O)NC1=NC2(CCc3c(cccc3C(=O)OC)C2)CO1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35
KMT2A Q03164 1/20 0.35
ALDH1A1 P00352 6/20 0.34
KDM4E B2RXH2 3/20 0.34
HSD17B10 Q99714 3/20 0.34
TRPA1 O75762 2/20 0.34
F2R P25116 1/20 0.34
HPGD P15428 3/20 0.33
DRD2 P14416 1/20 0.33
MAPT P10636 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CNR2 P34972 1/20 0.33
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7924679 0.91 TAAR1 (0.35) CYP1A2CYP2C19MEN1LMNAKMT2A
SCHEMBL7921745 0.87 F2R (0.38) CYP1A2CYP2C19SMN1; SMN2MEN1LMNA
SCHEMBL7911135 0.87 ALDH1A1 (0.34) CYP1A2CYP2C19SMN1; SMN2MEN1LMNA
SCHEMBL7922030 0.86 ALDH1A1 (0.34) CYP1A2CYP2C19SMN1; SMN2MEN1LMNA
SCHEMBL12230553 0.80 HPGD (0.39) CYP1A2CYP2C19SMN1; SMN2MEN1LMNA
SCHEMBL7923388 0.77 CYP1A2 (0.36) CYP1A2CYP2C19SMN1; SMN2MEN1LMNA
SCHEMBL12203757 0.76 SMN1; SMN2 (0.37) CYP1A2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL12203761 0.76 SMN1; SMN2 (0.37) CYP1A2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL12203758 0.76 SMN1; SMN2 (0.37) CYP1A2CYP2C19SMN1; SMN2MEN1KMT2A
SCHEMBL12203763 0.73 KDM4E (0.35) SMN1; SMN2ALDH1A1KDM4EHSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010042475-A1 SPIROAMINOOXAZOLINE ANALOGUES AS ALPHA2C ADRENERGIC RECEPTOR MODULATORS SCHERING CORPORATION (US) 2010-04-15 WO disclosed